Sikiric et al., Peptides (2018) A detailed exploration of BPC-157s cellular and molecular effects in experimental models
No reduced serum serotonin levels in patients with post-acute sequelae of COVID-19
After years of hard work trying to tan this literally changed my life
Compromised supply chains: temperature-sensitive medications need cold storage illegal sellers often cant guarantee that, reducing effectiveness and safety
Clinical evidence from the STEP trials demonstrated that participants using semaglutide lost between 15 and 22 percent of their starting body weight over approximately one year, though results depend on individual factors including genetics, adherence, and metabolic response
Before starting GLP-1 medications: Ensure you've had a recent diabetic eye screening (within the past 12 months) Discuss your retinopathy status with your prescribing clinician If you have known retinopathy, consider ophthalmology review before initiation Understand that gradual dose titration may help avoid very rapid changes in blood glucose, which is a general principle in diabetes management During treatment: Attend all scheduled diabetic eye screening appointments without fail If you have pre-existing retinopathy, your diabetes team may consider more frequent monitoring based on your individual clinical situation Control blood pressure to target levels (below 140/90 mmHg, or below 130/80 mmHg if you have kidney, eye or cerebrovascular damage, if tolerated) [13] Maintain good overall glycaemic control whilst avoiding excessively rapid HbA1c reductions when possible Stop smoking if applicable, as tobacco significantly worsens diabetic eye disease Manage cholesterol levels according to NICE guidance for cardiovascular risk reduction Communicate openly with your healthcare team about any visual symptoms, even if they seem minor
:max_bytes(150000):strip_icc()/Health-GettyImages-2219827987-cf32483d6c854df0ba239114420da85b.jpg)
